Physiotherapy practice in FR. Official registry identity, filed financial evidence and a public indicative value curve on one indexed company profile.
Historical indicative ranges based on public filings. This is not an asking price or confirmation that the company is for sale.
Based on filed company accountsThe historical value curve is public. Create a free account for the future five-year growth outlook, the insights behind it, and concrete action points that can increase this company’s value.
Free account · private workspace
Each step adds evidence that narrows the range. Public filings are a starting point. Connected accounts, owner context and method review make the valuation more useful for real decisions.
Own this company? Claim and manage the profileYou have seen the historical curve. Create a free account to explore a private five-year value scenario and the assumptions behind it.
The valuation for UNILABS AQUIBIO combines official public company figures with Upswitch sector calibration. The owner can sharpen it with their own figures and context into a full, defensible valuation curve.
Express interest and ask Upswitch to discreetly sound out the owner. We review every request before making contact.
This is an estimate, not an asking price. It is based on dated public sources and is not an owner forecast, offer, investment advice, or confirmation that the company is for sale.
Request verified control to add current figures, improve the profile and manage what happens next. We verify ownership before granting access.
UNILABS AQUIBIO, a physiotherapy practice, is registered at an address in France. The company was founded in 1979, incorporated as a 5785.
UNILABS AQUIBIO is listed in French National Business Register (RNE/INPI) under registry number 314911900. The public employee band is 21, a useful triage field for banks, credit analysts, and M&A acquirers. This profile consolidates official annual accounts into one indexable company dossier.
Within the French NACE 86.90 cluster, public-record data is filed annually via the national company registry.
Across the 2017-2024 window revenue has grown, moving from €9,496,544 to €10,728,049.
A public indicative value curve is available for UNILABS AQUIBIO, based on filed company accounts. A free account unlocks the five-year outlook and concrete actions to increase value.
The most recent annual filing covers 2024 (period end 2024-12-31).
The data on this page is a public, point-in-time projection of UNILABS AQUIBIO's regulator-filed footprint, built to support indicative valuation bands, sellability context, and acquisition research.
Public regulator-filed figures across 8 years.
Fiscal year | Revenue | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202431 Dec 2024 | €10,728,049 | - | €26,056,618 | €9,797,869 | - |
| 202331 Dec 2023 | €11,094,335 | - | €27,089,771 | €10,107,302 | - |
| 202231 Dec 2022 | €14,675,697 | - | €26,566,481 | €9,884,497 | - |
| 202131 Dec 2021 | €19,964,541 | - | €33,400,019 |
UNILABS AQUIBIO was founded in 1979 and is registered with French National Business Register (RNE/INPI), incorporated as a 5785.
UNILABS AQUIBIO is registered under NACE 86.90: NACE 86.90. That places the business within the French cluster for this activity.
This page shows a rounded, automated indicative range generated by Upswitch from official registry facts, public company-size information, filed accounts where available, and governed sector benchmarks. The evidence basis is labelled beside the graph. It is not a certified or statutory valuation, sale price, offer, recommendation, or financial, investment, tax or legal advice. Figures for UNILABS AQUIBIO may be incomplete or inaccurate and must not be relied upon for any transaction; a precise valuation needs owner- or advisor-supplied data.
Company identity and public facts are reused from the official or licensed source named on this page, with its filing or update date. Upswitch estimates remain distinct from source facts and do not imply endorsement by the registry. Natural-person enterprises are excluded from public valuation pages, and public registry personal data is not used for direct marketing.
Connected to this company and want something corrected? Request a correction or removal · Privacy policy · Terms & conditions · Data sources & evidence
| €9,093,510 |
| - |
| 202031 Dec 2020 | €15,006,826 | - | €31,179,270 | €5,901,480 | - |
| 201931 Dec 2019 | €10,048,359 | - | €27,353,298 | €3,481,385 | - |
| 201831 Dec 2018 | €9,583,150 | - | €27,665,175 | €3,924,988 | - |
| 201731 Dec 2017 | €9,496,544 | - | €27,634,794 | €3,548,761 | - |
The most recently filed annual accounts cover fiscal year 2024 (period end 2024-12-31), publicly available via French National Business Register (RNE/INPI).
